These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 27546847)

  • 21. Circulating and stool nucleic acid analysis for colorectal cancer diagnosis.
    De Maio G; Rengucci C; Zoli W; Calistri D
    World J Gastroenterol; 2014 Jan; 20(4):957-67. PubMed ID: 24574768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of proteomic patterns to screen for gastrointestinal malignancies.
    Feldman AL; Espina V; Petricoin EF; Liotta LA; Rosenblatt KP
    Surgery; 2004 Mar; 135(3):243-7. PubMed ID: 14976472
    [No Abstract]   [Full Text] [Related]  

  • 23. Stool markers for colorectal cancer screening: future considerations.
    Ahlquist DA; Gilbert JA
    Dig Dis; 1996; 14(3):132-44. PubMed ID: 8861521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incremental advances in excremental cancer detection tests.
    Itzkowitz SH
    J Natl Cancer Inst; 2009 Sep; 101(18):1225-7. PubMed ID: 19700654
    [No Abstract]   [Full Text] [Related]  

  • 25. Screening and surveillance in hereditary gastrointestinal cancers: Recommendations from the European Society of Digestive Oncology (ESDO) expert discussion at the 20th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona, June 2018.
    Vangala DB; Cauchin E; Balmaña J; Wyrwicz L; van Cutsem E; Güller U; Castells A; Carneiro F; Hammel P; Ducreux M; van Laethem JL; Matysiak-Budnik T; Schmiegel W
    Eur J Cancer; 2018 Nov; 104():91-103. PubMed ID: 30342310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disseminated tumour cells. Their detection and significance for prognosis of gastrointestinal and pancreatic carcinomas.
    Vogel I; Kalthoff H
    Virchows Arch; 2001 Aug; 439(2):109-17. PubMed ID: 11561750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting dynamics of subclones of GI, liver and pancreatic cancers.
    Ziogas DE; Glantzounis G; Liakakos T; Roukos DH
    Expert Rev Gastroenterol Hepatol; 2016 Jul; 10(7):773-6. PubMed ID: 27143511
    [No Abstract]   [Full Text] [Related]  

  • 28. Prognostic and predictive roles for circulating biomarkers in gastrointestinal cancer.
    De Mattos-Arruda L; Olmos D; Tabernero J
    Future Oncol; 2011 Dec; 7(12):1385-97. PubMed ID: 22112315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression analysis of MAC30 in human pancreatic cancer and tumors of the gastrointestinal tract.
    Kayed H; Kleeff J; Ding J; Hammer J; Giese T; Zentgraf H; Büchler MW; Friess H
    Histol Histopathol; 2004 Oct; 19(4):1021-31. PubMed ID: 15375745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Markers of angiogenesis and epidermal growth factor receptor signalling in patients with pancreatic and gastroesophageal junction cancer.
    Rohrberg KS; Skov BG; Lassen U; Christensen IJ; Høyer-Hansen G; Buysschaert I; Pappot H
    Cancer Biomark; 2010; 7(3):141-51. PubMed ID: 21263190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying molecular markers for the early detection of pancreatic neoplasia.
    Goggins M
    Semin Oncol; 2007 Aug; 34(4):303-10. PubMed ID: 17674958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New strategies for the early detection of pancreatic cancer.
    Petrone MC; Arcidiacono PG
    Expert Rev Gastroenterol Hepatol; 2016; 10(2):157-9. PubMed ID: 26582179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular markers for colorectal cancer screening.
    Dickinson BT; Kisiel J; Ahlquist DA; Grady WM
    Gut; 2015 Sep; 64(9):1485-94. PubMed ID: 25994221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatic cancer: Are "liquid biopsies" ready for prime-time?
    Lewis AR; Valle JW; McNamara MG
    World J Gastroenterol; 2016 Aug; 22(32):7175-85. PubMed ID: 27621566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Housekeeping gene variability in normal and cancerous colorectal, pancreatic, esophageal, gastric and hepatic tissues.
    Rubie C; Kempf K; Hans J; Su T; Tilton B; Georg T; Brittner B; Ludwig B; Schilling M
    Mol Cell Probes; 2005 Apr; 19(2):101-9. PubMed ID: 15680211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of Molecular Assays and Circulating Tumor DNA in Early-Stage Colorectal Cancer: A Roundtable Discussion of the Gastrointestinal Cancer Therapy Expert Group.
    Loaiza-Bonilla A; Benson AB; Grothey A; Karimi M; Klempner SJ; Lin D; Mahtani R; Soares HP
    Oncologist; 2021 Aug; 26(8):651-659. PubMed ID: 33650740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Point-of-care testing in the diagnosis of gastrointestinal cancers: current technology and future directions.
    Huddy JR; Ni MZ; Markar SR; Hanna GB
    World J Gastroenterol; 2015 Apr; 21(14):4111-20. PubMed ID: 25892860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers--a review.
    Minamoto T; Mai M; Ronai Z
    Cancer Detect Prev; 2000; 24(1):1-12. PubMed ID: 10757118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stool-based DNA tests for colorectal cancer: clinical potential and early results.
    Ahlquist DA
    Rev Gastroenterol Disord; 2002; 2 Suppl 1():S20-6. PubMed ID: 12439395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnosis of neuroendocrine tumours in the gastrointestinal tract].
    Rehfeld JF; Friis-Hansen L; Gøtze JP; Hilsted L; Nielsen FC
    Ugeskr Laeger; 2010 Oct; 172(43):2957-60. PubMed ID: 21040675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.